SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-012268
Filing Date
2023-08-15
Accepted
2023-08-15 17:53:39
Documents
2
Period of Report
2023-07-28

Document Format Files

Seq Description Document Type Size
1 form3-08152023_090832.html 3  
1 form3-08152023_090832.xml 3 1751
2 ex24-08152023_090833.htm EX-24 4796
  Complete submission text file 0001415889-23-012268.txt   8009
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLILN OH 43017
Business Address
Dais Craig (Reporting) CIK: 0001990095 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35076 | Film No.: 231175976